Diabetes Care, Vol 23, Issue 3 278-282, Copyright © 2000 by American Diabetes Association

ARTICLES

Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report

SC Lim, ES Tai, BY Tan, SK Chew and CE Tan
Department of Endocrinology, Singapore General Hospital, Singapore. geclsc@sgh.gov.sg

OBJECTIVE: In 1997, the American Diabetes Association (ADA) recommended a new diagnostic category, impaired fasting glucose (IFG), to describe individuals with borderline glucose tolerance. On the other hand, the World Health Organization (WHO) suggested retaining the category of impaired glucose tolerance (IGT). We studied the prevalence of IFG and IGT in a multiethnic society and compared the cardiovascular risk profiles of subjects with IFG, IGT, or both IFG and IGT. RESEARCH DESIGN AND METHODS: A total of 3,568 subjects were examined from the 1992 National Health Survey of Singapore, which involved a combination of disproportionately stratified sampling and systematic sampling. Anthropometric, blood pressure, insulin, lipid profile, and uric acid measurements were taken, and a standard 75-g oral glucose tolerance test was performed after a 10-h overnight fast. RESULTS: The prevalence rates of IFG only, IGT only, and both IFT and IGT were 3.45, 10.2, and 3.4%, respectively. The degree of agreement (kappa) between the two diagnostic criteria (the ADA IFG and the WHO IGT) was only 0.25. A fasting glucose level of 5.5 mmol/l was the optimal cutoff for predicting a 2-h postload glucose level of > or =7.8 mmol/l. The following cardiovascular risk factors were higher in subjects with both IFG and IGT compared with those with either IFG or IGT alone: systolic blood pressure (131 +/- 20 vs. 125 +/- 21 and 125 +/- 19 mmHg, respectively; P < 0.05 and P < 0.001, respectively); diastolic blood pressure (77 +/- 12 vs. 73 +/- 12 and 74 +/- 12 mmHg, respectively; P < 0.05); BMI (26.2 +/- 4.2 vs. 24.4 +/- 4.0 and 24.6 +/- 4.4 kg/m2, respectively; P < 0.01 and P < 0.001, respectively); waist circumference (84.1 +/- 10.3 vs. 79.3 +/- 10.7 and 79.3 +/- 10.6 cm, respectively; P < 0.001); waist-to-hip ratio (0.84 +/- 0.08 vs. 0.82 +/- 0.09 and 0.81 +/- 0.08, respectively; P < 0.05 and P < 0.001, respectively); fasting insulin (12.1 +/- 9.7 vs. 9.2 +/- 5.3 and 9.9 +/- 7.7 mU/l; P < 0.01); insulin resistance (by homeostasis model assessment [HOMA]) (3.41 +/- 2.77 vs. 2.58 +/- 1.50 and 2.43 +/- 1.83, respectively; P < 0.01 and P < 0.001, respectively); total cholesterol (5.81 +/- 1.1 vs. 5.51 +/- 1.1 and 5.53 +/- 1.1 mmol/l, respectively; P < 0.05) and apolipoprotein(B) [apo(B)] (1.5 +/- 0.38 vs. 1.40 +/- 0.34 and 1.39 +/- 0.35 mmol/l, respectively; P < 0.01). The pattern of difference remained significant only for fasting insulin, insulin resistance (HOMA), and apo(B) (borderline) after adjustment for age, sex, and ethnic differences. CONCLUSIONS: Obvious discordance was evident in the classification of glycemic status when applying the criteria proposed by the ADA (IFG) or WHO (IGT) in a multiethnic society like Singapore. However, subjects with either IFG or IGT had similar cardiovascular risk profiles. Therefore, both criteria identified individuals at high risk for cardiovascular disease. Individuals with both IFG and IGT had a greater incidence of the cardiovascular dysmetabolic syndrome.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. R. Rizzo, A. M. Abbatecola, M. Barbieri, M. T. Vietri, M. Cioffi, R. Grella, A. Molinari, R. Forsey, J. Powell, and G. Paolisso Evidence for Anti-Inflammatory Effects of Combined Administration of Vitamin E and C in Older Persons with Impaired Fasting Glucose: Impact on Insulin Action J. Am. Coll. Nutr., August 1, 2008; 27(4): 505 - 511. [Abstract] [Full Text] [PDF]

				D.-T. Lin-Tan, J.-L. Lin, L.-H. Wang, L.-M. Wang, L.-M. Huang, L. Liu, J.-Y. Huang, and Y.-L. Huang Fasting Glucose Levels in Predicting 1-Year All-Cause Mortality in Patients Who Do Not Have Diabetes and Are on Maintenance Hemodialysis J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2385 - 2391. [Abstract] [Full Text] [PDF]

				D. M. Nathan, M. B. Davidson, R. A. DeFronzo, R. J. Heine, R. R. Henry, R. Pratley, and B. Zinman Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care Diabetes Care, March 1, 2007; 30(3): 753 - 759. [Full Text] [PDF]

				S. M. Haffner Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B20 - B25. [Abstract] [Full Text] [PDF]

				F. J. Novoa, M. Boronat, P. Saavedra, J. M. Diaz-Cremades, V. F. Varillas, F. La Roche, M. P. Alberiche, and A. Carrillo Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation: The Telde Study Diabetes Care, October 1, 2005; 28(10): 2388 - 2393. [Abstract] [Full Text] [PDF]

				C. Nielson and T. Lange Blood Glucose and Heart Failure in Nondiabetic Patients Diabetes Care, March 1, 2005; 28(3): 607 - 611. [Abstract] [Full Text] [PDF]

				E. S. Tai, S. Y. Goh, J. J.M. Lee, M.-S. Wong, D. Heng, K. Hughes, S. K. Chew, J. Cutter, W. Chew, K. Gu, et al. Lowering the Criterion for Impaired Fasting Glucose: Impact on disease prevalence and associated risk of diabetes and ischemic heart disease Diabetes Care, July 1, 2004; 27(7): 1728 - 1734. [Abstract] [Full Text] [PDF]

				K. Ohshita, K. Yamane, M. Hanafusa, H. Mori, K. Mito, M. Okubo, H. Hara, and N. Kohno Elevated White Blood Cell Count in Subjects With Impaired Glucose Tolerance Diabetes Care, February 1, 2004; 27(2): 491 - 496. [Abstract] [Full Text] [PDF]

				M.-S. Wong, K. Gu, D. Heng, S.-K. Chew, L.-S. Chew, and E. S. Tai The Singapore Impaired Glucose Tolerance Follow-Up Study: Does the ticking clock go backward as well as forward? Diabetes Care, November 1, 2003; 26(11): 3024 - 3030. [Abstract] [Full Text] [PDF]

				S. Ma, J. Cutter, C. E. Tan, S. K. Chew, and E. S. Tai Associations of Diabetes Mellitus and Ethnicity with Mortality in a Multiethnic Asian Population: Data from the 1992 Singapore National Health Survey Am. J. Epidemiol., September 15, 2003; 158(6): 543 - 552. [Abstract] [Full Text] [PDF]

				H. Ohnishi, S. Saitoh, S. Takagi, J.-i. Ohata, T. Isobe, Y. Kikuchi, H. Takeuchi, and K. Shimamoto Pulse Wave Velocity as an Indicator of Atherosclerosis in Impaired Fasting Glucose: The Tanno and Sobetsu Study Diabetes Care, February 1, 2003; 26(2): 437 - 440. [Abstract] [Full Text] [PDF]

				E. Ferrannini Pre-diabetes: to treat or not to treat? The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1_suppl): S2 - S5. [Abstract] [PDF]

				B. L. Rodriguez, R. D. Abbott, W. Fujimoto, B. Waitzfelder, R. Chen, K. Masaki, I. Schatz, H. Petrovitch, W. Ross, K. Yano, et al. The American Diabetes Association and World Health Organization Classifications for Diabetes: Their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men Diabetes Care, June 1, 2002; 25(6): 951 - 955. [Abstract] [Full Text] [PDF]